Goldman Sachs – Talk Bio

Actionable Insights Powered by AI

Ironwood Pharmaceuticals’ Stock Plummets Following Layoffs and FDA Setback for Apraglutide

1 week ago talkbio0Tagged Biotechnology, Goldman Sachs, Ironwood, Phase 3 Clinical Trials, plunge, regulatory hurdle, Short Bowel Syndrome, strategic alternatives, United States Food and Drug Administration

Ironwood Pharmaceuticals , apraglutide , short bowel syndrome (SBS) , Phase III trial , layoffs , FDA regulatory hurdle , stock plunge , strategic alternatives , Goldman Sachs , biotechnology

Pfizer Weighs Sale of Hospital Drugs Unit Amid Activist Pressure

5 months ago talkbio0Tagged activist investor, Goldman Sachs, hospital drugs unit, Pfizer, Sales - occupational activity, Starboard Value

Pfizer, hospital drugs unit, sale, activist investor, Starboard Value, Goldman Sachs